GLP-1 Telehealth: What PMHNPs Need to Know in Michigan

You didn’t go to medical school to become a weight-loss doctor. But here’s the reality: nearly half of psychiatrists are already prescribing or recommending GLP-1 medications like Ozempic and Wegovy — and for good reason. Your patients are asking for help with medication-induced weight gain. They’re struggling with obesity that compounds their depression and anxiety. And there’s a massive, underserved market of patients who can’t access traditional obesity specialists.

The opportunity is real: by 2025, an estimated 20 million Americans were taking GLP-1 drugs, with demand still far outpacing provider supply. But here’s the critical question: how do you tap into this growth without adding unsustainable workload to an already demanding psychiatric practice?

This guide breaks down exactly how psychiatrists can build, scale, and sustain a profitable GLP-1 practice — covering patient acquisition, telehealth compliance, cash vs. insurance models, and the workflow systems that prevent burnout.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

You’re Already Solving the Problem

Many of your current patients are ideal candidates for GLP-1 therapy. Antipsychotics, mood stabilizers, and certain antidepressants commonly cause significant weight gain — a side effect patients consistently cite as a reason for medication non-compliance. By offering GLP-1 treatment, you address this directly within the therapeutic relationship you’ve already built.

Beyond medication side effects, psychiatric patients frequently struggle with binge eating disorder, emotional overeating, or obesity that worsens their mental health outcomes. Unlike a primary care doctor who sees patients for 15 minutes twice a year, you have ongoing relationships and expertise in behavioral change — two critical factors in successful long-term weight management.

The Mental Health Connection Matters

Early research suggests GLP-1 medications may have independent psychiatric benefits, including improvements in mood and reduced addictive behaviors. As a psychiatrist, you’re equipped to monitor these effects and manage any mood changes that occasionally arise during treatment. (The FDA investigated rare reports of suicidal ideation linked to GLP-1s in 2023-24 but found no causal relationship and directed removal of suicide warnings from labels. Still, your mental health expertise adds a safety layer other weight-loss providers can’t match.)

The Market Demand Is Staggering

From 2018 to 2024, GLP-1 usage for weight loss increased roughly 600%. In 2024, about 2% of Americans were using these medications for obesity; by late 2025, that number had tripled to approximately 6% — with tens of thousands of new patients starting treatment weekly. Yet there’s a critical shortage of obesity medicine specialists to serve this population.

This supply-demand imbalance creates an opening for psychiatrists willing to expand their scope. And unlike highly competitive mental health markets in major cities, the GLP-1 space still has plenty of room for new providers.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Acquire GLP-1 Patients: Three Proven Channels

Channel 1: Convert Existing Psychiatric Patients

The easiest patients to acquire are already in your practice. Start by reviewing your current caseload for patients with:

• BMI ≥30 (or ≥27 with comorbidities like hypertension or diabetes)
• Weight gain from psychiatric medications
• Expressed concerns about weight or body image
• Co-occurring binge eating or emotional eating patterns

During medication management visits, introduce the conversation naturally: ‘I know the Seroquel has been helping your mood, but I’ve noticed you’ve mentioned weight gain a few times. Have you heard about the new GLP-1 medications? I’m now offering those as part of comprehensive psychiatric care.’

This internal conversion strategy requires zero marketing spend and leverages established trust. Patients appreciate that you’re treating them holistically rather than referring them elsewhere.

Channel 2: Partner with Telehealth Platforms

Telehealth platforms specializing in GLP-1 care have invested heavily in patient acquisition and can instantly connect you with high patient volume. The key difference from traditional marketing: you only pay when qualified patients book appointments.

Here’s the economic reality of DIY marketing vs. platforms:

DIY Marketing Costs:

• SEO typically requires 6-12 months of consistent investment ($2,000-5,000/month for quality content, technical optimization, and link building) before generating meaningful patient flow
• Google Ads for mental health and weight-loss keywords cost $15-40+ per click, with most clicks not converting to booked patients — realistic cost per booked patient runs $200-400+
• Psychology Today and similar directories charge $30-60/month but you’re competing with hundreds of other providers on the same page
• Total monthly marketing spend for a solo provider trying to DIY: $3,000-5,000+ with uncertain ROI

Platform Model (like Klarity Health):

• Pay-per-appointment model — you only pay a standard listing fee when a qualified patient books with you
• No upfront marketing spend or monthly subscriptions
• Patients are pre-matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient options
• You control your schedule and patient volume

The platform model removes marketing risk entirely. Instead of gambling thousands on campaigns that might not convert, you pay only for results — qualified patients who show up for appointments.

Channel 3: Strategic Marketing and Referrals

If you prefer to build your own patient base, focus on these high-ROI tactics:

Local Physician Outreach: Primary care doctors are overwhelmed with weight-loss requests but lack time for ongoing GLP-1 management. Send a brief email or drop off a one-pager: ‘I’m a board-certified psychiatrist now offering medical weight management via telehealth. I provide comprehensive care for patients on GLP-1 medications, including mental health monitoring that’s often overlooked. I’ll keep you updated on shared patients and refer back for routine medical care.’

Content Marketing: Create blog posts and social media content targeting ‘GLP-1 and mental health,’ ‘weight loss for psychiatric patients,’ or ‘psychiatrist-led weight management.’ This differentiates you from generic weight-loss clinics and attracts patients who value integrated care.

Therapist and Dietitian Referrals: Mental health therapists and nutritionists often work with clients whose weight-loss efforts stall due to untreated psychological factors or the need for medication support. Let them know you can complement their work.

Set Realistic Expectations: Don’t position GLP-1s as miracle vanity drugs. Emphasize medical necessity, sustainable weight loss, and combining medication with lifestyle changes. This messaging attracts motivated patients more likely to stay engaged long-term.

GLP-1 Telehealth Compliance: What You Must Know

Prescribing GLP-1 Medications Is Legally Straightforward

GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide are not controlled substances, which means:

• The federal Ryan Haight Act’s in-person exam requirement doesn’t apply
• You can legally prescribe via telehealth without ever seeing the patient in person
• No DEA registration complications

You must, however:

• Hold an active medical license in the state where the patient is located (just like any telemedicine practice)
• Meet the standard of care: conduct a thorough video evaluation, obtain informed consent, document appropriately
• Follow state-specific telehealth requirements (e.g., California requires patient consent for telehealth; some states have specific modality rules)

State-by-State Licensing and Scope Nuances

For Psychiatrists (MD/DO): You have full prescriptive authority for GLP-1 medications in every state. The only requirement is proper licensure:

• California, New York: Require full in-state medical license (not in Interstate Medical Licensure Compact)
• Texas, Pennsylvania, Illinois, Florida: Are IMLC members, which expedites multi-state licensure for physicians

For Psychiatric NPs (PMHNPs): Scope of practice varies significantly by state:

If you’re an NP in a collaborative state, partnering with a supervising physician (or joining a platform that provides this) is essential. Many telehealth companies will pair you with a collaborating MD or restrict certain states to physician-only practice.

Telehealth Modality and Documentation Requirements

Most states allow you to establish the patient relationship via synchronous audio-visual (video) consultation. Key points:

• California: Requires documented patient consent for telehealth
• Texas: Allows pure telehealth relationships; audio-only permitted for mental health but generally requires video for medical evaluations
• Florida: Allows out-of-state physicians to register for telehealth (can’t prescribe Schedule II controlled substances via telehealth, but GLP-1s are fine)
• Standard of care across all states: Obtain adequate medical history, perform appropriate evaluation (weight, BMI, health conditions), document contraindications, provide informed consent about medication risks/benefits

Off-Label Prescribing and Compounded Medications

Many providers prescribe semaglutide off-label for weight loss (Ozempic is FDA-approved for diabetes; Wegovy for obesity). Off-label prescribing is legal but requires clear patient education and documentation.

Compounded semaglutide has become popular due to lower cost, but comes with considerations:

• Ensure your compounding pharmacy is properly licensed and FDA-compliant
• The FDA has issued warnings about unregulated compounders
• Document why you’re using compounded vs. FDA-approved medications (typically cost-accessibility)
• Some state boards are scrutinizing compounding quality — stick with reputable partners

Cash-Pay vs. Insurance: The Economic Reality

Why Most GLP-1 Practices Run Cash-Pay

While most insurers cover GLP-1 drugs for diabetes, coverage for obesity is extremely limited:

• As of mid-2024, only 13 state Medicaid programs covered GLP-1s for weight loss (including California, Pennsylvania, and Illinois)
• Most commercial insurance plans exclude weight-loss medications
• Even when covered, prior authorizations are extensive and reimbursement is often inadequate

This insurance gap has created a robust cash-pay market. Patients are willing to pay out-of-pocket because the medications work — and the results are life-changing.

Cash-Pay Model Economics

Typical Structure:

• Initial consultation: $150-300
• Follow-up visits (monthly during titration): $75-150
• Some practices offer monthly subscription packages: $200-400/month including consultations, medication coordination, and coaching support

Medication costs patients pay:

• Brand-name Wegovy: $1,300+/month without insurance
• Compounded semaglutide: $200-400/month
• Some telehealth platforms include compounded medication in subscription price

Provider Revenue Example:

• 50 active GLP-1 patients on monthly follow-up model
• Average $100/visit × 50 patients = $5,000/month
• Time investment: ~15-20 minutes per follow-up = 12-17 clinical hours/month
• Effective hourly rate: $300-400+

This revenue is additional to your psychiatric practice and requires no insurance billing headaches.

Insurance Model: When It Makes Sense

Accepting insurance for GLP-1 visits can expand access to patients who can’t afford cash-pay. Consider this approach if:

• You’re already credentialed and have efficient insurance billing systems
• You want to serve a broader socioeconomic patient base
• Your state Medicaid covers GLP-1 medications (increasing likelihood of full coverage)

Billing codes:

• Standard E/M codes for obesity management (99213/99214)
• Medicare G0447 (behavioral counseling for obesity) — though Medicare doesn’t cover GLP-1 drugs yet, this may change as pilot programs expand

The catch: Extensive documentation requirements, prior authorizations for medications (even when visits are covered), and lower reimbursement rates. Many providers use a hybrid model: charge cash for initial comprehensive evaluation, then bill insurance for routine follow-ups if the patient has coverage.

Scaling Your GLP-1 Practice Without Burning Out

The demand exists. Patients are eager. But how do you handle 50, 100, or 200+ GLP-1 patients while maintaining your psychiatric practice and personal life?

Workflow Optimization: Systematize Everything

1. Streamlined Intake Process

Create digital intake forms that collect comprehensive information before the first visit:

• Complete weight and diet history
• Current medications and medical conditions
• Mental health screening (depression, anxiety, eating disorder history)
• Contraindication checklist (thyroid cancer history, pancreatitis, pregnancy)

This pre-visit work saves 10-15 minutes per initial consult and ensures nothing is missed.

2. Standardized Order Sets

Build order set templates in your EHR:

• ‘Obesity Intake Panel’: A1c, fasting glucose, TSH, CMP (liver/kidney function)
• Follow-up monitoring: periodic A1c, lipid panel if indicated
• One-click ordering saves time and ensures consistency

3. Clinical Protocols and Checklists

Develop standard protocols for:

• GLP-1 dose titration schedules
• Managing common side effects (nausea, constipation, injection site reactions)
• When to order additional labs or refer to specialists
• Patient education resources (diet, exercise, realistic expectations)

Using checklists ensures every patient gets evidence-based care and reduces decision fatigue.

Follow-Up Cadence: Right-Size Your Involvement

Intensive Phase (Months 1-3):

• Monthly visits during dose titration
• Monitor side effects, adjust medication, provide behavioral support
• These visits can be brief (15-20 minutes) with efficient workflows

Maintenance Phase (Month 4+):

• Every 2-3 months once stable on therapeutic dose
• Quarterly visits for ongoing monitoring, motivation, relapse prevention

Use asynchronous check-ins between visits: patients report weight via app or portal, you review and message brief feedback. This maintains engagement without requiring synchronous appointments.

Delegation: Build a Team-Based Model

You should not be doing everything. Effective delegation is the difference between a scalable practice and burnout:

Medical Assistants/RNs:

• Collect interim vital signs and weight data
• Handle routine patient questions via portal
• Triage issues: ‘Is this nausea normal or does the doctor need to know?’
• Schedule appointments and medication refills

Health Coaches or Dietitians:

• Conduct dietary counseling and exercise planning
• Lead monthly group support sessions (educate multiple patients at once)
• Provide motivation and accountability between doctor visits

Billing/Admin Staff:

• Handle insurance prior authorizations if you accept insurance
• Coordinate with compounding pharmacies
• Manage patient payment and collections

By delegating non-specialist tasks, you focus on medication decisions and complex cases — your highest-value work.

Technology: Leverage Automation

Telehealth Platform Features:

• Integrated video, e-prescribing, and secure messaging
• Automated appointment reminders (reduces no-shows)
• Patient self-scheduling for follow-ups
• Template documentation speeds charting

Remote Monitoring Tools:

• Connected scales or weight-tracking apps
• Patients log weekly weights; you review graphed trends at a glance
• Intervene only when progress stalls or concerns arise

AI and Chatbots:

• Automate FAQs: ‘How do I inject? What if I have nausea?’
• Pre-visit questionnaires auto-populate your note

These tools compress appointment time and improve patient experience — winning combination.

Group Visits: Multiply Your Impact

Consider monthly group telehealth sessions:

• 30-45 minute Zoom with 10-15 patients
• Educational topic (nutrition, exercise, managing setbacks)
• Q&A and peer support

Patients value community and learning from others. You provide efficient education to many at once instead of repeating the same information in individual visits. Some practices charge separately for group sessions; others include them in monthly subscription fees.

Set Clear Boundaries to Protect Your Time

Calibrate Patient Volume Gradually:

• Start with one or two half-days per week dedicated to GLP-1 patients
• Scale up only when workflows are smooth and you’re comfortable
• Resist the temptation to fill every slot immediately

Define Availability:

• Set specific hours for patient messaging (e.g., respond 9am-5pm weekdays)
• Use delayed send or auto-responders outside business hours
• Patients need boundaries as much as you do

Maintain Practice Variety:

• Many psychiatrists keep a mix of mental health and weight-management patients
• Variety prevents monotony and keeps clinical skills broad
• Others fully transition to obesity medicine — either path works if intentional

Monitor Your Own Burnout Indicators

Watch for signs you’re overextended:

• Emotional exhaustion or dreading patient visits
• Declining quality of documentation or patient interactions
• Resentment toward patients or practice

When these arise:

• Temporarily cap new patient intake
• Hire additional support staff or a part-time NP/PA to share the load
• Take scheduled time off (telehealth flexibility should enhance work-life balance, not erode it)

Research shows that schedule control and flexible work arrangements significantly reduce physician burnout. You built a telehealth GLP-1 practice for autonomy — protect that by setting sustainable pace.

Invest in Training and Community

Pursue obesity medicine education:

• CME courses or formal certification (American Board of Obesity Medicine)
• Join online communities (Obesity Medicine Association, telehealth clinician forums)
• Learn from peers managing large GLP-1 panels

Confidence reduces stress. When you know how to handle edge cases and have a network to consult, practice feels manageable rather than overwhelming.

The Bottom Line: A Sustainable Path to Growth

The GLP-1 weight-loss boom presents a massive opportunity for psychiatrists — but only if approached thoughtfully. Here’s the sustainable path:

1. Start small: Convert a few existing patients or join a telehealth platform that handles patient acquisition
2. Systematize ruthlessly: Build intake processes, clinical protocols, and delegation structures from day one
3. Scale gradually: Add patient volume only when workflows are running smoothly
4. Leverage technology and team: You’re the medical decision-maker; delegate everything else
5. Protect your boundaries: Set clear availability, monitor burnout signs, take time off

Done right, a GLP-1 practice delivers:

• Meaningful additional revenue with high hourly rates
• The satisfaction of dramatically improving patients’ physical and mental health
• Flexibility to scale up or down based on your capacity
• Differentiation in a crowded psychiatric market

The demand isn’t going away. Tens of thousands of patients each week are seeking providers who can guide them through GLP-1 therapy. With your psychiatric expertise in behavior change and mental health, you’re uniquely positioned to meet this need — and build a thriving, sustainable practice in the process.

Frequently Asked Questions

Do I need special certification to prescribe GLP-1 medications?

No. As a licensed psychiatrist (MD/DO), you can prescribe GLP-1 medications within your scope of practice. Obesity medicine certification is optional but can enhance your knowledge and marketing credibility. Psychiatric NPs should ensure they meet their state’s prescribing requirements (collaboration agreements in some states).

How do I handle patients who just want GLP-1s for vanity weight loss?

Set clear criteria: you’re treating obesity as a medical condition (BMI ≥30 or ≥27 with comorbidities), not cosmetic concerns. Conduct thorough evaluations to ensure medical necessity. Patients seeking purely cosmetic use may be better served elsewhere — and clearer medical indications reduce your liability.

What if a patient has psychiatric side effects on GLP-1s?

This is where your psychiatric expertise shines. Monitor mood, anxiety, and suicidal ideation during follow-ups. The FDA found no causal link between GLP-1s and suicide, but vigilance is appropriate. If concerning symptoms arise, adjust the dose, add supportive therapy, or discontinue if needed. Document your clinical reasoning.

Can I prescribe GLP-1s to patients in other states via telehealth?

Only if you hold a medical license in the patient’s state. Some states (like Florida for physicians) offer special telehealth registrations for out-of-state providers. Check each state’s requirements before treating patients there. Platforms like Klarity often handle multi-state credentialing complexities.

How do I compete with online GLP-1 mills advertising $199/month?

Differentiate on quality and comprehensive care. Emphasize that you’re a board-certified psychiatrist (not a nurse practitioner with minimal supervision), that you address mental health factors affecting weight loss, and that you provide ongoing medical monitoring — not just a prescription mill. Patients seeking the cheapest option may not be your ideal clientele anyway.

What’s a realistic patient panel size for one provider?

With efficient systems, one full-time provider can manage 100-200 active GLP-1 patients (mix of monthly and quarterly follow-ups). At 15-20 minutes per visit, that’s roughly 20-30 clinical hours per month for GLP-1 care. Part-time providers (one or two half-days weekly) can comfortably handle 30-50 patients.

Should I use brand-name medications or compounded semaglutide?

Both have roles. Brand-name FDA-approved drugs (Wegovy, Saxenda) offer regulatory certainty but cost $1,000+/month without insurance. Compounded semaglutide costs $200-400/month, making treatment accessible to more patients — but ensure you partner with reputable, licensed compounding pharmacies. Discuss options and document patient preference.

How do I bill insurance if I choose to accept it?

Use standard E/M codes (99213/99214/99215) for obesity management visits. Document medical necessity thoroughly (BMI, comorbidities, prior weight-loss attempts). Some insurers also recognize obesity-specific codes like G0447. Be prepared for prior authorizations on medications — this is where the insurance model becomes labor-intensive.

Ready to tap into the GLP-1 opportunity without the marketing gamble? Klarity Health connects psychiatrists and psychiatric NPs with pre-qualified patients seeking weight-loss treatment via telehealth. You control your schedule, pay only when patients book, and leverage built-in infrastructure for seamless care delivery. Learn more about joining Klarity’s provider network at Klarity Health.

References

1. Axios. ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage). May 27, 2025. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews. ‘GLP-1 drugs reshaping health, diet and food industry.’ October 20, 2025. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is